- Home
- MRNA vs NDSN Comparison
MRNA vs NDSN Comparison
Compare MRNA & NDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | NDSN |
|---|---|---|
| Founded | 2010 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 12.9B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | NDSN |
|---|---|---|
| Price | $27.57 | $238.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | $33.91 | ★ $265.33 |
| AVG Volume (30 Days) | ★ 9.9M | 314.2K |
| Earning Date | 11-06-2025 | 12-10-2025 |
| Dividend Yield | N/A | ★ 1.37% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.95 |
| Revenue | $2,232,000,000.00 | ★ $2,784,349,000.00 |
| Revenue This Year | N/A | $6.21 |
| Revenue Next Year | $0.77 | $4.45 |
| P/E Ratio | ★ N/A | $30.05 |
| Revenue Growth | N/A | ★ 4.49 |
| 52 Week Low | $22.28 | $165.03 |
| 52 Week High | $48.92 | $258.63 |
Technical Indicators
Market Signals| Indicator | MRNA | NDSN |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 60.48 |
| Support Level | $23.92 | $233.14 |
| Resistance Level | $26.00 | $240.67 |
| Average True Range (ATR) | 1.29 | 4.27 |
| MACD | 0.32 | 0.63 |
| Stochastic Oscillator | 99.82 | 89.75 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NDSN Nordson Corporation
Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.7 billion in revenue in its fiscal 2024.